Landmark clinical results suggest preventative therapy could delay or halt Alzheimer’s onset in high-risk individuals, reshaping the outlook …
Landmark clinical results suggest preventative therapy could delay or halt Alzheimer’s onset in high-risk individuals, reshaping the outlook …
An established diagnostics firm gains critical funding to advance its wearable glucose monitoring technology and drive a strategic …
Large funding rounds and strategic partnerships highlight a more focused investment environment, concentrating on companies with late stage …
Two key players in immunology and vaccine innovation gain financial momentum as they push forward with mRNA vaccines …
A wave of major financings and collaborations on February 25 signals renewed investor confidence in biotech, with giants …
A landmark multi-hundred million dollar collaboration between Takeda and BridGene Biosciences redefines biotech funding trends this week, joined …
The European regulatory body’s February 2025 meeting brings fresh treatment options for immunodeficiency and autoimmunity among other conditions, …
At ECCO 2025 in Berlin, Sanofi and Teva presented the first detailed findings from the RELIEVE UCCD study …
Roche introduces an ultra-rapid and scalable next-generation sequencing method poised to accelerate genomic research and potentially reshape clinical …
February 2025 sees a surge in large-scale biotech investments—from Eikon’s massive Series D to critical autoimmune and oncology …
